Suzhou Sanegene Bio
As of the edition of 20 October 2026, Suzhou Sanegene Bio runs 5 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 3 |
| Status not established | 2 |
| Total | 5 |
Where its trials are
- Nutrition and metabolism: 2 trials led
- Blood and lymph: 1 trials led
- Heart and blood vessels: 1 trials led